Pyxus International, Inc.

PYYX: 8-K · proxy statement

Pyxus International held its 2026 annual meeting of shareholders on August 13, 2026, where shareholders elected all seven director nominees — John S. Alphin, Jamie J. Ashton, Patrick J. Bartels, Jr., Robert D. George, Cynthia P. Moehring, J. Pieter Sikkel and Richard J.C. Topping — to one-year terms expiring at the 2027 annual meeting. Shareholders overwhelmingly ratified Deloitte & Touche LLP as the Company's independent auditors for the fiscal year ending March 31, 2027, with 20,237,672 votes for and only 635 against. The advisory say-on-pay resolution approving named executive officer compensation was adopted with 18,392,358 votes for versus 748,737 against, indicating broad shareholder support; all proposals passed with no contested items or surprises.

SEC 8-K•2mo ago

Pyxus International, Inc. Announces First Quarter Fiscal Year 2027 Financial Results Earnings Call

Pyxus International announced that it will release its fiscal first quarter 2027 financial results before the market opens on August 5, 2026. The company will host a conference call and webcast at 9 a.m. EDT on the same day to discuss the quarterly results with investors and analysts. Access details for the call and webcast were provided, with an archived recording to be made available shortly after the event concludes.

•3mo ago

PYYX: DEF 14A · proxy statement

Pyxus International, Inc. has filed its definitive proxy statement for the 2026 annual shareholder meeting scheduled to be held virtually on August 13, 2026. The Board of Directors recommends that shareholders vote for the election of seven director nominees, including incumbent CEO J. Pieter Sikkel, and for the ratification of Deloitte & Touche LLP as the company's independent auditor for the fiscal year ending March 31, 2027. The filing discloses executive compensation for fiscal year 2026, reporting that CEO J. Pieter Sikkel received total compensation of approximately $1.82 million. Additionally, the proxy details the company's shareholder agreement, which grants Glendon Capital Management and Monarch Alternative Capital specific rights to nominate board members and influence the election of the Board Chairperson based on their ownership stakes. As of the record date, there were 24,607,791 shares of common stock outstanding and entitled to vote. The proxy statement also includes an advisory vote on executive compensation, known as say-on-pay, for which the Board recommends a vote in favor.

SEC DEF 14A•3mo ago

PYYX: 10-K · periodic report

Pyxus International, Inc. reported fiscal 2026 revenue of $2.41 billion, a 2.8% decline year-over-year, driven by lower average prices per kilo in Africa and reduced volumes in value-added tobacco products. Despite the revenue dip, gross profit expanded by 1.4% to $347.7 million, benefiting from cost efficiencies in larger crops and increased processing volumes in Africa and North America. The company ended the fiscal year with $932.9 million in total debt and $134.3 million in cash, resulting in net debt of $798.6 million. Liquidity remains tight but manageable, with $747.3 million available across its ABL credit facility and foreign seasonal lines of credit, though management noted that liquidity needs may approach available limits during peak working capital periods. Pyxus highlighted significant concentration risk, with Philip Morris International, China National Tobacco, and Japan Tobacco International each accounting for over 10% of sales. The filing also disclosed that two significant shareholders, Glendon Capital and Monarch Alternative Capital, collectively own approximately 59% of the company, granting them substantial control over corporate matters.

SEC 10-K•4mo ago

Pyxus International, Inc. Announces Fourth Quarter and Full Year Fiscal Year 2026 Financial Results Earnings Call

Pyxus International announced it will release its fourth quarter and full year fiscal 2026 financial results on June 4, 2026. The company will hold an earnings conference call and webcast at 9 a.m. EDT on that date to discuss the results. This release serves only as a scheduling notice; no financial data or guidance is included.

•5mo ago